Alchemist gets nod for slump sale of pharma division

13 Feb 2020 Evaluate

Alchemist has received an approval for slump sale of the Pharma Division of the company, on going concern basis, subject to the approval of the shareholders of the company through postal ballot, statutory and other applicable approvals. The Board of Directors of the company in its meeting held on February 12, 2020, approved the same.

Alchemist is engaged in the business of steel, floriculture, pharma, information technology, food processing and international business. The company also in the business segment of Agri Business, Pharma and Chemicals. 

Alchemist Share Price

3.01 0.00 (0.00%)
13-Dec-2021 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.